ArticleJournal of molecular histology2026
Evaluation of the healing efficiency of mucoadhesive Ocimum basilicum solid lipid nano particles oral gel versus Oracure® gel in the treatment of induced buccal ulcer in rats.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral mucosal ulcerations are prevalent and debilitating conditions that impair functions such as mastication and speaking. Ocimum basilicum (Basil) is a plant rich in anti-inflammatory and antioxidant phytochemicals that promote healing. Solid lipid nanoparticles (SLNs) serve as drug delivery system to enhance the bioavailability and absorption of encapsulated herbal compounds. This work aimed to assess the healing efficiency of Ocimum basilicum solid lipid nanoparticles (B-SLNs) oral gel compared to commercial Oracure® gel on induced buccal ulcers in rats. Buccal ulcers were induced in fifty-four adult male rats using 50% acetic acid for 60 s. The rats were divided into three groups: one untreated (positive control) and two experimental groups treated with B-SLNs gel or Oracure® gel (0.5mg, three times) daily. Six animals from each group were euthanized at 3, 5, and 7 days. Buccal tissues were excised and analyzed via histological and histomorphometric examinations, as well as immunofluorescent localization of vascular endothelial growth factor (VEGF). Tissue levels of interleukin-10 (IL-10), tumor necrosis factor-α (TNF-α), superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH) were measured using enzyme-linked immunosorbent assays (ELISA). The B-SLNs gel significantly reduced ulcer size and increased VEGF, IL-10, SOD, and GSH levels versus positive control (p < 0.001). The treated groups had lower TNF-α and MDA levels than the positive control (p < 0.001), while B-SLNs had notably lower levels than Oracure group. B-SLNs oral gel showed greater potential for treating chemically induced buccal ulcers in rats compared to commercial Oracure® gel.
Indexed as
Identifiers
42432397What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.